Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:CRS
NYSE:CRSAerospace & Defense

Is It Too Late To Consider Carpenter Technology (CRS) After A 93% One Year Rally?

If you are wondering whether Carpenter Technology's share price still reflects fair value after a strong run, you are not alone. The stock closed at US$385.04, with returns of 1.4% over 7 days, 14.7% over 30 days, 13.8% year to date and 93.0% over the past year, plus a very large gain over 3 and 5 years. Recent headlines around Carpenter Technology have focused on its role as a specialty materials supplier in aerospace and industrial markets, alongside broader interest in suppliers tied to...
TSE:8987
TSE:8987Office REITs

A Look At Japan Excellent (TSE:8987) Valuation After Updated 2026 Earnings And Distribution Guidance

Japan Excellent (TSE:8987) issued fresh 2026 guidance, outlining expected revenues, profits and distributions for each half of the year, with a modest reduction in first half payouts and a slight increase projected for the second half. See our latest analysis for Japan Excellent. The guidance update comes after a period of steady share price gains, with Japan Excellent’s share price at ¥154,200 and a 1 year total shareholder return of 25.1%, while multi year total shareholder returns also...
NYSE:NKE
NYSE:NKELuxury

Evaluating Nike (NKE) Valuation After Recent Weak Share Price Performance

Recent performance snapshot NIKE (NKE) shares closed at US$63.09, with recent returns showing a 3.5% decline over the past day, broadly flat performance over the past week, and negative moves over the month and past 3 months. See our latest analysis for NIKE. At around US$63, NIKE’s recent 1 day and 1 month share price declines sit against a much weaker 1 year total shareholder return of 19.6% and a 5 year total shareholder return of 50.9%. This suggests momentum has been fading and investors...
NYSE:DD
NYSE:DDChemicals

A Look At DuPont (DD) Valuation After Recent Share Price Momentum And Undervaluation Signals

DuPont de Nemours (DD) has caught investor attention after a strong past 3 months, with the stock showing a 29.1% total return. Recent business metrics offer more context for that move. See our latest analysis for DuPont de Nemours. That recent 29.1% three month total return sits alongside a 13.5% one month share price gain and a 49.5% one year total shareholder return. This suggests momentum has been building around DuPont de Nemours at the current US$50.08 share price. If this kind of move...
NasdaqGS:WGS
NasdaqGS:WGSHealthcare

GeneDx Holdings (WGS) Q4 Loss Of US$17.7 Million Tests Bullish Profitability Narrative

GeneDx Holdings (WGS) closed out FY 2025 with Q4 revenue of US$121.0 million and a basic EPS loss of US$0.61, alongside net income excluding extraordinary items of a US$17.7 million loss. Over recent quarters the company has seen revenue move from US$95.6 million in Q4 2024 to US$121.0 million in Q4 2025, while quarterly basic EPS has ranged from a loss of US$0.31 in Q3 2024 to a gain of US$0.38 in Q2 2025 and back to a loss of US$0.61 in the latest period. This sets up a story in which...
NasdaqGS:PNTG
NasdaqGS:PNTGHealthcare

What Pennant Group (PNTG)'s Earnings After Prior Guidance Beat Means For Shareholders

The Pennant Group (NASDAQ: PNTG), a senior living and home health provider, recently reported earnings after market close, following a prior quarter in which it exceeded revenue expectations and issued full-year revenue guidance above analyst estimates. With analysts maintaining their forecasts and projecting very strong year-on-year revenue growth for the latest quarter, investor attention has focused on whether Pennant’s operating momentum and guidance can sustain this level of...
TSE:6503
TSE:6503Electrical

Is Mitsubishi Electric (TSE:6503) Turning HR Overhaul Into a Deeper Culture Shift for Investors?

Mitsubishi Electric’s board meeting on February 19, 2026 resulted in past organizational restructuring, including renaming its Corporate Human Resources Group to the Corporate Human Resources & Culture Transformation Group and consolidating culture initiatives into HR. The concurrent reshuffle of senior executive roles, including enhanced mandates for technology strategy, human resources, risk management and global planning, signals a coordinated push to align leadership with internal reform...
NasdaqGS:PECO
NasdaqGS:PECORetail REITs

Assessing Phillips Edison (PECO) Valuation After Recent Share Price Momentum

Why Phillips Edison (PECO) is Back on Investor Radars Phillips Edison (PECO) has quietly drawn fresh attention after recent gains over the month and past 3 months, prompting investors to reassess this grocery anchored shopping center owner and its current valuation. See our latest analysis for Phillips Edison. Phillips Edison’s recent momentum, with a 30 day share price return of 10.88% and year to date gain of 11%, sits alongside a 1 year total shareholder return of 14.39%, suggesting steady...
NYSE:IVZ
NYSE:IVZCapital Markets

Assessing Invesco (IVZ) Valuation After Recent Share Price Volatility

Invesco (IVZ) is back in focus after recent share price moves, with the stock down about 11% over the past month but up roughly 4% in the past 3 months. See our latest analysis for Invesco. The recent weakness, including a 4.76% 1 day share price decline and an 11.23% 30 day share price pullback to US$25.21, sits against a much stronger 48.94% 1 year total shareholder return. This suggests that momentum has cooled after a solid run. If this volatility has you looking beyond asset managers, it...
NYSE:KR
NYSE:KRConsumer Retailing

What Kroger (KR)'s CEO Change and New Partnerships Strategy Means For Shareholders

Kroger recently appointed Greg Foran as Chief Executive Officer and expanded its initiatives through EVgo fast-charging installations, Home Chef’s Giada De Laurentiis collaboration, and enhanced Verified Savings support for SNAP customers. Together, these moves highlight Kroger’s emphasis on leadership stability, convenience-focused partnerships, and value offerings aimed at deepening customer loyalty across its grocery ecosystem. We’ll now examine how Greg Foran’s appointment as CEO may...
NasdaqGM:ACMR
NasdaqGM:ACMRSemiconductor

Is Seldon’s Stake Cut Amid ACMR’s Expansion Plans Altering The Investment Case For ACM Research (ACMR)?

Earlier in 2026, Seldon Capital disclosed a US$6.83 million sale of 183,242 ACM Research shares, markedly reducing its ownership position as the company tightened its 2025 revenue outlook and outlined expectations for continued growth in 2026. This combination of a major shareholder stepping back while ACM Research scales revenue toward the billion-dollar level and invests in new U.S. capacity highlights a tension between institutional positioning and management’s expansion plans. Next,...
NasdaqGS:INCY
NasdaqGS:INCYBiotechs

Is It Time To Reassess Incyte (INCY) After A 36% One-Year Share Price Gain?

If you are wondering whether Incyte at around US$100.85 is priced for its future or leaving some value on the table, this article walks through what the numbers are really saying about the stock. Over the past week Incyte declined 0.3%. Over 30 days it declined 1.1%. Over the last year it returned 36.3%, with 3-year and 5-year returns of 31.6% and 26.6% respectively. These figures can naturally raise questions about where it sits on the risk and reward spectrum today. Recent headlines around...
NYSE:DGX
NYSE:DGXHealthcare

How Investors May Respond To Quest Diagnostics (DGX) Earnings Beat, Higher Dividend And Expansion Plans

In February 2026, Quest Diagnostics reported higher fourth-quarter and full-year 2025 sales and earnings, issued 2026 guidance calling for US$11.70–US$11.82 billion in revenue and US$9.45–US$9.65 in diluted EPS, raised its quarterly dividend to US$0.86 per share, and disclosed continued share repurchases under its long-running buyback program. The company also signaled continued expansion by pursuing hospital outreach and independent lab acquisitions, while using its questhealth.com platform...
NYSE:FLO
NYSE:FLOFood

How Investors May Respond To Flowers Foods (FLO) Dividend Hike Amid Losses And Boardroom Turnover

Flowers Foods, Inc. recently reported Q4 2025 results showing sales of US$1,232.86 million but a net loss of US$67.07 million, driven in part by a US$135.98 million impairment of intangible assets, while also issuing 2026 sales guidance of US$5.16 billion to US$5.27 billion, indicating a 1.8% to 0.2% change from the prior year. Despite weaker profitability and upcoming retirements of long-serving directors George E. Deese and Edward J. Casey, Jr., the board approved a 3.1% increase in the...
NYSE:FUBO
NYSE:FUBOInteractive Media and Services

Evaluating FuboTV (FUBO) Valuation After Steep Share Price Pressure And Discounted Sales Multiple

FuboTV stock after recent performance FuboTV (FUBO) has been under pressure recently, with the share price at US$1.18 and negative returns over the past week, month, past 3 months and year to date drawing fresh attention from investors. See our latest analysis for FuboTV. The recent 1 day share price return of a 4.84% decline adds to a 30 day share price return of a 52.42% decline and a year to date share price return of a 54.44% decline, which points to fading momentum as investors reassess...
NasdaqGS:BEAM
NasdaqGS:BEAMBiotechs

Beam Therapeutics Taps US$500m Non Dilutive Debt To Back Risto Cel

Beam Therapeutics entered a long term, non dilutive financing agreement with Sixth Street to support the potential launch of its sickle cell gene therapy. The deal provides access to up to $500 million in capital tied to Beam’s commercial plans for this program. The agreement focuses on funding potential product launch and commercialization activities rather than issuing new equity. For investors watching NasdaqGS:BEAM, this financing move comes with the stock trading around $28.33 and a...
SWX:PSPN
SWX:PSPNReal Estate

How Revaluation-Fueled Earnings And A Higher Dividend At PSP Swiss Property (SWX:PSPN) Has Changed Its Investment Story

PSP Swiss Property recently reported its 2025 results, with net income rising on property revaluations, a portfolio of about CHF 10.10 billion, and a proposed dividend increase to CHF 3.95 per share. An interesting angle is that the higher dividend comes even as underlying earnings softened, underscoring management’s reliance on revaluation gains and confidence in funding major redevelopment projects from a strong balance sheet. We’ll now examine how the higher dividend proposal, underpinned...
NasdaqGS:DRS
NasdaqGS:DRSAerospace & Defense

SHIELD Contract Access, Dividend And Guidance Could Be A Game Changer For Leonardo DRS (DRS)

Leonardo DRS, Inc. has reported past fourth-quarter 2025 sales of US$1,060 million and net income of US$102 million, raised full-year 2025 results versus 2024, declared a US$0.09 per-share cash dividend, and issued 2026 sales guidance of US$3,850 million to US$3,950 million while also securing access to a very large US$151 billion SHIELD IDIQ contract ceiling. An interesting angle for investors is how the combination of higher earnings per share, a new cash dividend, and eligibility to...
TSE:6278
TSE:6278Machinery

Does Union Tool’s (TSE:6278) 65th-Anniversary Payout Hint At Evolving Capital Discipline?

Union Tool Co. has already gone ex-dividend for a special ¥5.00 cash payout linked to its Dec-29-2025 year-end dividend, lifting the total annual dividend to ¥130 per share including a ¥70 year-end payment. This 65th-anniversary commemorative dividend underlines the company’s emphasis on shareholder returns and its willingness to share surplus cash with investors. We will now examine how this enhanced and commemorative dividend shapes Union Tool’s investment narrative, particularly around...
NZSE:FRW
NZSE:FRWLogistics

Freightways Group (NZSE:FRW) Valuation After Strong Half Year Results And New Dividend Announcement

Why Freightways Group’s latest earnings and dividend matter for investors Freightways Group (NZSE:FRW) has just reported half year 2025 results, with sales of NZ$718.16 million and net income of NZ$52.35 million, alongside a declared cash dividend of NZ$0.2471 per share. See our latest analysis for Freightways Group. At a share price of NZ$14.50, Freightways Group has posted a 3.57% 90 day share price return and a 39.88% 1 year total shareholder return. This suggests recent earnings and...
ENXTPA:ENX
ENXTPA:ENXCapital Markets

How Euronext’s 2025 Earnings and Higher Dividend Proposal Will Impact Euronext (ENXTPA:ENX) Investors

Euronext N.V. has reported its fourth-quarter and full-year 2025 results, with revenue rising to €456.4 million for the quarter and €1.82 billion for the year, while net income reached €144.7 million in Q4 and €642.9 million for 2025. The company is also proposing a €321.5 million dividend, equal to half of 2025 reported net income and almost 10% higher than last year, underscoring its focus on shareholder returns alongside product expansion and cost control. With this higher proposed...
CPSE:FLS
CPSE:FLSMachinery

FLSmidth Leadership Reset Sharpens Focus On Mining Technology Performance

FLSmidth (CPSE:FLS) has completed its shift into a pure-play mining technology provider following the divestment of its cement business. The company has appointed Toni Laaksonen as CEO and announced a reshaped Board, including a new proposed Chair and several departures. New executives have been named to lead key mining business lines, signaling an organizational reset around the mining portfolio. FLSmidth now trades as a focused mining technology and services company, with its...
NYSE:FCX
NYSE:FCXMetals and Mining

Freeport-McMoRan (FCX) Valuation Check After Strong Recent Share Price Momentum

Freeport-McMoRan: recent performance puts copper miner in focus Freeport-McMoRan (FCX) is drawing investor attention after recent share price moves, with the stock up 1.9% over the past day, 4.3% in the past week, and 8.5% over the past month. See our latest analysis for Freeport-McMoRan. Those recent gains build on a stronger trend, with a 90 day share price return of 59.61% and a 1 year total shareholder return of 79.09%, suggesting momentum has been building over both shorter and longer...
NasdaqGS:ISRG
NasdaqGS:ISRGMedical Equipment

Should Analyst Optimism Around Intuitive’s Robotic, Diagnostic, and AI Tools Require Action From Intuitive Surgical (ISRG) Investors?

In recent weeks, Intuitive Surgical has drawn attention as analysts highlighted its continued leadership in robotic-assisted surgery, supported by the entrenched da Vinci platform, expanding Ion diagnostic offering, and ongoing innovation in AI-driven tools. The news underscores how Intuitive’s wide clinical moat and growing mix of recurring instrument, accessory, and digital revenues may help counter rising competition, tariffs, and regulatory challenges. Next, we’ll examine how this...